ALXO ALX Oncology: Prakiraan rega marang bathi

ALXO (ALX Oncology) - tandha merek perusahaan

The valuation of ALX Oncology Holdings (ALXO) depends on the progress of clinical trials, as commercial revenue and pricing power are currently absent. The company's expected NTM P/E helps identify hidden market manipulations, while the 0.00 metric determines this level. The biopharma developer is creating less toxic CD47 blockers to combat tumors, competing for best-in-class status in a niche with a high risk of side effects.

alxoncology.com - Pangali mangsa ngarep rega marang bathi ALXO (periode 04.07.2022 - 18.11.2026)

Rincian metrik lan analitis perusahaan ALX Oncology Holdings Inc. (ALXO)

Analisis fundamental perusahaan:alxoncology.com ALXO
Produk mawa merek ALX Oncology

The forward P/E determines the stock price relative to projected earnings, measuring market expectations for business efficiency over future periods. By analyzing the forward P/E chart for ALX Oncology Holdings (ALXO), an investor can see how the diversification of ALX Oncology Holdings (ALXO) clinical programs targeting various tumors reduces regulatory risks, creating a fundamental margin of safety and justifying the issuer's current valuation.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Janux Therapeutics Inc - Prakiraan rega marang bathi|Arcus Biosciences (RCUS) - Rasio prakiraan rega marang bathi|ZYME: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TNGX (Tango Therapeutics, Inc.)|IOVA: Pangali Forward P/E|IMTX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep xencor.com|Prakiraan rega marang bathi compasstherapeutics.com (CMPX)|Rega marang bathi mangsa ngarep Replimune Group Inc (REPL)|Prakiraan rega marang bathi Lyell Immunopharma Inc LYEL|Innate Pharma SA - Prakiraan rega marang bathi|Pangali Forward P/E Pyxis Oncology, Inc. PYXS|CGEN - Rega marang bathi mangsa ngarep|IOBT (iobiotech.com) - Rasio rega marang bathi mangsa ngarep|Sutro Biopharma, Inc (STRO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MiNK (INKT)|Prakiraan rega marang bathi HOWL|IMMX - Pangali forward rega marang bathi|Pangali Forward P/E CUE|Rasio kapitalisasi marang bathi mangsa ngarep PDSB|Pangali Forward P/E SONN (Sonnet BioTherapeutics)|Pangali mangsa ngarep rega marang bathi MAIA|liminatuspharma.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi LAVA Therapeutics|NextCure, Inc. (NXTC) - Rega marang bathi mangsa ngarep|Leap Therapeutics Inc - Pangali mangsa ngarep rega marang bathi|INTS (Intensity Tx) - Pangali Forward P/E|Pangali Forward P/E senseibio.com|Rega marang bathi mangsa ngarep Theriva Biologics (TOVX)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E